Search results
Feb 15, 2023 · Safe and effective vaccines against coronavirus disease 2019 (Covid-19) are urgently needed in young children. Methods. We conducted a phase 1 dose-finding study and are conducting an ongoing...
Dec 20, 2022 · Firstly, studies in children can be difficult owing to the specific characteristics of covid-19 in this age group. For example, children with SARS-CoV-2 infections tend to have mild or no symptoms; this could lead to many undetected infections and an underestimate of vaccine effectiveness.
November 23, 2021. Covid 19 vaccines for our vulnerable children. Ediriweera Desapriya, PhD | Department of Pediatrics, Faculty of Medicine, UBC. The first clinical trial study published last week in the New England Journal of Medicine (NEJM) shows very promising results.
- Lindsay A Thompson, Sonja A Rasmussen, Sonja A Rasmussen
- 2021
1 day ago · Table 2 Characteristics of COVID-19 vaccination and/or infection in children aged 5-11 and 12-17 years who received at least one COVID-19 vaccine dose or tested positive for SARS-CoV-2 in England ...
Jun 30, 2022 · For children, BNT162b2 (Pfizer–BioNTech), an mRNA-based vaccine against SARS-CoV-2, was authorised in May, 2021, for adolescents aged 12–15 years and in December, 2021, for those aged 5–11 years. In The Lancet, Chiara Sacco and colleagues report the effectiveness of BNT162b2 in children aged 5–11 years after the omicron variant (B.1.1. ...
Sep 9, 2022 · Nicola P Klein. Published: September 09, 2022 DOI: https://doi.org/10.1016/S1473-3099 (22)00575-8. PlumX Metrics. By February 2022, European and US agencies recommended use of the BNT162b2 mRNA COVID-19 vaccine (Pfizer–BioNTech) as a primary two-dose series in children aged 5–11 years and as a booster dose in adolescents aged 12–15 years. ,
Mar 3, 2022 · Talha Khan Burki. Published: March 03, 2022 DOI: https://doi.org/10.1016/S2213-2600 (22)00085-6. COVID-19 vaccination in young children. On Feb 16, 2022, the UK Joint Committee on Vaccination and Immunisation (JCVI) issued a statement recommending that all children aged 5–11 years should be offered the COVID-19 vaccine.
